1. Home
  2. Directory
  3. Oklahoma
  4. City
  5. Colon Rectal Surgery
  6. NPI Profile
  7. Prescriptions 1760635890

DR. WILLIAM CONAN MUSTAIN M.D.
Prescription History 1760635890
Colon & Rectal Surgery in Oklahoma City, OK

NPI Status: Active since November 03, 2008

Contact Information

4205 MCAULEY BLVD STE 301
OKLAHOMA CITY, OK
ZIP 73120
Phone: (405) 936-5718
Fax: (405) 936-5719

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. WILLIAM CONAN MUSTAIN M.D., an active Colon & Rectal Surgery specialist practicing in Oklahoma City, OK. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 116 documented patient claims. Among these therapy options, the most frequently utilized medication is Metronidazole, which accounts for 49 claims alone.

Medication Index

E
I
M
P
No matching medications currently found on file.

Erythromycin

Generic Formulation: Erythromycin BaseSpecialty: Colorectal Surgery (Proctology)
Provider Metrics Summary
Total Claims 40
30-Day Fills 40.0
Days Supply 45
OK State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills46.2
Peer Average Days Supply584
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,944.60 across this reporting matrix range.

Provider Avg Cost Per Claim

$73.62

State Avg Cost Per Claim

$21.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Erythromycin is used to treat a wide variety of bacterial infections. It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Imiquimod

Generic Formulation: ImiquimodSpecialty: Colorectal Surgery (Proctology)
Provider Metrics Summary
Total Claims 12
30-Day Fills 16.0
Days Supply 462
OK State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills30.7
Peer Average Days Supply810
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 57.1% less volume than the regional standard for practitioners inside OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $468.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$39.01

State Avg Cost Per Claim

$51.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial CARCINOMA, BASAL CELL; and ACTINIC KERATOSIS.

Therapeutic Applications

This medication is used to treat certain types of growths on the skin. These are precancerous growths (actinic keratoses), a certain type of skin cancer (superficial basal cell carcinoma), and warts on the outside of the genitals/anus. Treating these conditions can decrease complications from them. Imiquimod belongs to a group of drugs called immune response modifiers. It is believed to work by helping to activate your immune system to fight these abnormal skin growths. This product is not recommended for use on children under 12 years of age unless specifically directed by your doctor.

Metronidazole

Generic Formulation: MetronidazoleSpecialty: Colorectal Surgery (Proctology)
Provider Metrics Summary
Total Claims 49
30-Day Fills 49.0
Days Supply 49
OK State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills21.8
Peer Average Days Supply346
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 133.3% higher than the standard regional baseline profile for OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $74.57 across this reporting matrix range.

Provider Avg Cost Per Claim

$1.52

State Avg Cost Per Claim

$35.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.

Therapeutic Applications

This medication is used on the skin to treat a certain skin disorder known as rosacea, a type of adult acne. It may help to decrease redness, swelling and the number of pimples caused by rosacea. This medication is an antibiotic. For the treatment of rosacea, metronidazole is believed to work by decreasing swelling (inflammation). Some brands of this medication also contain sunscreens (see also Notes section).

Pantoprazole Sodium

Generic Formulation: Pantoprazole SodiumSpecialty: Colorectal Surgery (Proctology)
Provider Metrics Summary
Total Claims 15
30-Day Fills 21.0
Days Supply 630
OK State Average Benchmarks
Peer Average Claims86.0
Peer Average 30-Day Fills168.9
Peer Average Days Supply4,956
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 82.6% less volume than the regional standard for practitioners inside OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $414.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$27.66

State Avg Cost Per Claim

$18.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.

Therapeutic Applications

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. WILLIAM CONAN MUSTAIN M.D. provides transparency into local medical care patterns within Oklahoma City, OK.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Colon & Rectal Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.